Amid the Biden administrations recent proposal to expand obesity drug coverage under Medicare and Medicaid, experts at Real Chemistry examined which state Medicaid programs currently cover GLP-1s approved to treat obesity and how much they are spending
What to Expect After Skyla Insertion Many people experience temporary adjustment symptoms after the IUD is placed
The rate of use of various drugs differed between countries, from 32 for every 100,000 pregnancies in the Nordic countries to almost 300 for every 100,000 pregnancies in the U.S
This level of efficacy approaching the kind of weight loss previously seen only with bariatric surgery has been a game changer in obesity treatment
Ozempic is approved in the U.S., so you should be fine bringing it on your flight
The SURMOUNT-4 trial for tirzepatide, which shares some receptor targets with retatrutide, showed that participants who stopped the drug regained about two-thirds of their lost weight within a year